[HTML][HTML] Fluvoxamine vs placebo and clinical deterioration in outpatients with symptomatic COVID-19: a randomized clinical trial
EJ Lenze, C Mattar, CF Zorumski, A Stevens… - Jama, 2020 - jamanetwork.com
Importance Coronavirus disease 2019 (COVID-19) may lead to serious illness as a result of
an excessive immune response. Fluvoxamine may prevent clinical deterioration by …
an excessive immune response. Fluvoxamine may prevent clinical deterioration by …
[引用][C] Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19
EJ Lenze, C Mattar, CF Zorumski, A Stevens… - JAMA, 2020 - cir.nii.ac.jp
Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19
| CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
| CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial.
EJ Lenze, C Mattar, CF Zorumski… - JAMA: Journal of …, 2020 - search.ebscohost.com
Abstract < bold> Importance: </bold> Coronavirus disease 2019 (COVID-19) may
lead to serious illness as a result of an excessive immune response. Fluvoxamine may …
lead to serious illness as a result of an excessive immune response. Fluvoxamine may …
[PDF][PDF] Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 A Randomized Clinical Trial
EJ Lenze, C Mattar, CF Zorumski, A Stevens… - …, 2020 - euroclinic.gr
OBJECTIVE To determine whether fluvoxamine, given during mild COVID-19 illness,
prevents clinical deterioration and decreases the severity of disease. DESIGN, SETTING …
prevents clinical deterioration and decreases the severity of disease. DESIGN, SETTING …
[PDF][PDF] Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 A Randomized Clinical Trial
EJ Lenze, C Mattar, CF Zorumski, A Stevens… - …, 2020 - academia.edu
OBJECTIVE To determine whether fluvoxamine, given during mild COVID-19 illness,
prevents clinical deterioration and decreases the severity of disease. DESIGN, SETTING …
prevents clinical deterioration and decreases the severity of disease. DESIGN, SETTING …
[PDF][PDF] Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 A Randomized Clinical Trial
EJ Lenze, C Mattar, CF Zorumski, A Stevens… - …, 2020 - amedeolucente.it
OBJECTIVE To determine whether fluvoxamine, given during mild COVID-19 illness,
prevents clinical deterioration and decreases the severity of disease. DESIGN, SETTING …
prevents clinical deterioration and decreases the severity of disease. DESIGN, SETTING …
[PDF][PDF] Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 A Randomized Clinical Trial
EJ Lenze, C Mattar, CF Zorumski… - …, 2020 - regenhealthsolutions.info
OBJECTIVE To determine whether fluvoxamine, given during mild COVID-19 illness,
prevents clinical deterioration and decreases the severity of disease. DESIGN, SETTING …
prevents clinical deterioration and decreases the severity of disease. DESIGN, SETTING …
[PDF][PDF] Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 A Randomized Clinical Trial
EJ Lenze, C Mattar, CF Zorumski, A Stevens… - …, 2020 - amedeolucente.it
OBJECTIVE To determine whether fluvoxamine, given during mild COVID-19 illness,
prevents clinical deterioration and decreases the severity of disease. DESIGN, SETTING …
prevents clinical deterioration and decreases the severity of disease. DESIGN, SETTING …
[PDF][PDF] Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 A Randomized Clinical Trial
EJ Lenze, C Mattar, CF Zorumski, A Stevens… - …, 2020 - webpoisoncontrol.org
OBJECTIVE To determine whether fluvoxamine, given during mild COVID-19 illness,
prevents clinical deterioration and decreases the severity of disease. DESIGN, SETTING …
prevents clinical deterioration and decreases the severity of disease. DESIGN, SETTING …
[PDF][PDF] Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 A Randomized Clinical Trial
EJ Lenze, C Mattar, CF Zorumski, A Stevens… - …, 2020 - poison.org
OBJECTIVE To determine whether fluvoxamine, given during mild COVID-19 illness,
prevents clinical deterioration and decreases the severity of disease. DESIGN, SETTING …
prevents clinical deterioration and decreases the severity of disease. DESIGN, SETTING …